Comment from Notification and Comment Center on Technical Barriers to Trade for the State Administration for Market Regulation, China

Summary: The government of the People's Republic of China opposes the proposed classification of blood irradiators, arguing that the FDA's "intended use" logic creates unnecessary trade barriers and deviates from international standards. They request a unified regulatory classification based on inherent hazards, mutual recognition of international testing data, and reduced compliance costs for small and medium-sized enterprises.